Update Series Volume 40 (2021)
For the most timely topics and latest surgical techniques in urology, you won't want to miss the 2021 AUA Update Series—AUA's most popular self-study CME product.
- Concise, practical lessons on timely topics including state-of-the-art surgical techniques
- Authors and Editors are among the best in their specialties
- Study questions available within the Test Your Knowledge activities
- 3 ways to enjoy the content – online, audio, print
- 40 hours of CME credit
Now in its 40th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology.
40 lessons delivered to you five lessons a month for eight months.
Convenient, easy-to-access education that fits your individual learning style.
- Online and audio book version via AUAUniversity or the AUAU app
- Traditional printed book
Audio Lessons - Listen on-the-go!
This enhanced feature is FREE to all Update Series subscribers. Stream audio recordings of all 40 lessons conveniently from your mobile device! Audio Lessons are released in coordination with their online companion lessons.
For a limited time, AUA Members can access Update Series 2020 Audio Lessons for FREE! Click the banner at the top of the AUAUniversity app to start streaming!
Earn up to 40 AMA PRA Category 1 Credits™
Subscribers can obtain CME credit instantly! Simply complete the content-related, online posttests to receive immediate CME credit.
Online & Audio (single-user)
Online, Print & Audio (single-user)*
Letter of verification may be required.
International Resident/Fellow Member
|International Resident/Fellow Non-Member|
*Print copy is not sold separately. Shipping Fees: U.S. and Canada, add shipping fee of $6.95; International, add shipping fee of $45.00.
The American Urological Association designates this enduring material for a maximum of 40 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Board candidates
After completing all 40 lessons, participants, will be able to apply their knowledge and competencies on the urologic topics covered in each article. Each of the 40 lessons has a specific objective specific to the related article.
Update Series Advisory Group
|Benjamin Newell Breyer, MD, FACS||Nothing to disclose|
|Michael S. Cookson, MD, MMHC||TesoRx Pharma LLC||Consultant or Advisor|
|Astellas Pharma, Inc.||Consultant or Advisor|
|Merck||Consultant or Advisor|
|Bayer Healthcare Pharmaceuticals||Consultant or Advisor|
|Ferring Pharmaceuticals||Consultant or Advisor|
|Myovant Sciences||Consultant or Advisor|
|E. Ann Gormley, MD||American Board of Medical Subspecialties||Leadership Position|
|Cheryl Taylore Lee, MD||Merck||Consultant or Advisor|
|Brian R. Matlaga, MD, MPH||Boston Scientific||Consultant or Advisor|
|John Patrick Mulhall, MD||The Journal of Sexual Medicine||Leadership Position|
|Vault||Consultant or Advisor|
|Curtis Nickel, MD, FRCSC||National Institutes of Health||Scientific Study or Trial|
|Canadian Institute of Health Research||Scientific Study or Trial|
|RedLeaf Medical||Scientific Study or Trial|
|MicroGenDx||Scientific Study or Trial|
|Inmunotek||Scientific Study or Trial|
|Valensa||Scientific Study or Trial|
|TEVA||Consultant or Advisor|
|Farr Laboratories||Consultant or Advisor|
|Alivio Therapeutics||Consultant or Advisor|
|Seikagaku Corporation||Consultant or Advisor|
|JT Pharma||Consultant or Advisor|
|Craig Stuart Niederberger, MD||American Society for Reproductive Medicine||Leadership Position|
|Ferring Pharmaceuticals||Scientific Study or Trial|
|J. Kellogg Parsons, MD, MHS||Dendron||Consultant or Advisor|
|Boston Scientific||Consultant or Advisor|
|Stacy T. Tanaka, MD, MS, FAAP, FACS||Centers for Disease Control and Prevention (CDC)||Scientific Study or Trial|
|Journal of Urology||Health Publishing|
|J. Christian Winters, MD||StimGuard||Consultant or Advisor|
|Christopher S. Saigal, MD||WiseCare||Consultant or Advisor|
|Ceeva||Consultant or Advisor|
CME CREDITS EXPIRATION:
Please note: CME Credits expire after three years of original release date. Answers must be submitted by the CME credits expiration deadline to receive credit for that year. Refer to CME expiration table below:
|CME Credits Expiration Date|
|2021 Update Series||Month, 2024|
|2020 Update Series||Month, 2023|
|2019 Update Series||Month, 2022|
|2018 Update Series||Month, 2021|
|2017 and prior||Not eligible for CME credits.|
This self-study continuing medical education activity is designed to provide urologists, Board candidates and/or residents affordable and convenient access to the most recent developments and techniques in urology.
METHOD OF PARTICIPATION:
Participants recieve 5 lessons per month for 8 months for a total of 40 lessons. Each lesson is designated for a maximum of 1.0 AMA PRA Category 1 CreditTM. To earn credit, participants must read the educational material provided for each lesson, pass its corresponding online posttest with at least 80% accuracy, submit the online evaluation and claim CME.
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Urological Association designates this enduring material for a maximum of 40.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
EVIDENCE BASED CONTENT:
It is the policy of the AUA to ensure that the content contained in this CME enduring material activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA DISCLOSURE POLICY:
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST:
All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group for identification of conflicts of interest. The AUA COI Review Work Group, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or AUA COI Review Work Group.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:
It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
Reproduction of written materials developed for this AUA activity is prohibited without the written permission from individual authors and the American Urological Association.
Peer review is the principle mechanism by which the quality of the AUA Update Series content is judged by the AUA Update Series Advisory Board.
Released date: Release month, 2021
Expiration date: Release month, 2024
- 40.00 AMA PRA Category 1 Credit™
- 40.00 Non-Physician Participation
All Update Series content is available online. Due to the impact of COVID-19, the mailing of print versions could be delayed. Know that we will work to complete your order as soon as possible. We thank you for your patience and look forward to continuing to serve you.
Please log in to see your member rate and purchase.
Subscribers will be emailed each of the 8 scheduled release months when lessons become available. Lessons may be accessed through the AUAUniversity under My Activities tab and through the Quick Links tab.
Scheduled 2021 release months: January, March, April, June, August, September, November, and December